LONDON — Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth …
WASHINGTON — A unique peek inside the human brain may help explain how it clears away waste like the kind that can build up and lead to Alzheimer’s disease. Brain …
Scientists have discovered a new drug that could blast toxic protein tangles in the brain that lead to Alzheimer’s. The first-of-its-kind drug could provide fresh hope to millions living with …
My husband of 52 years wanted to die at home, but he could not do so under California’s End of Life Option Act. A retired psychologist, voracious reader, and enthusiastic …
Obesity is widely recognised as a global crisis, but one health expert has warned of a more insidious trend that’s wreaking havoc on our health and shortening lifespans. Speaking to …
Today marks World Alzheimer’s Day, a significant date dedicated to raising awareness and offering support for individuals and families coping with the disease. Alzheimer’s is a prevalent type of dementia …
Startling research suggests that people with untreated high blood pressure have a significantly worsened risk of dementia. Australian researchers examined data from more than 30,000 individuals across 14 different countries …
Hannah Yoon | The Washington Post | Getty Images Leqembi, an Alzheimer’s drug from Biogen and Eisai, isn’t a cure for the mind-damaging disease. But the treatment promises to give …
In a remarkable scientific stride, new research suggests that individuals with multiple sclerosis (MS) may possess a genetic edge that helps shield them from Alzheimer’s, igniting fresh hope for experts …
LONDON — Britain’s drug regulator authorized the Alzheimer’s drug Leqembi on Thursday, saying it’s the first medicine to show some impact in slowing the progression of the neurodegenerative disease. But …